Kim Baden-Kristensen

Brain+ ApS

Kim Baden-Kristensen is the CEO and Co-founder of Brain+, specializing in digital therapeutics for brain rehabilitation and remediation.

The award winning Brain+ apps are validated in clinical pilot trials and are undergoing large scale pivotal clinical trials in Brain injury (TBI and stroke), Parkinson’s disease and Major depressive disorder patients. Brain+ also works on presymptomatic detection and prevention of Alzheimer’s disease in collaboration with leading European universities, providers, and patient organizations, including Alzheimer Europe and the European Brain Council.

Kim is a founding member of the Digital Therapeutics Partnership, a global non-for-profit with a mission to enhance patient outcomes and quality of care with clinically-validated digital therapeutics. He is intensively engaged in health care policy making initiatives on the European level.

Kim is recognized as an authority within digital cognitive therapeutics, with particularly emphasis on neurogame-based rehabilitation and “gamified” rehabilitation.

Kim holds an MSc. In Innovation Management from Copenhagen Business School, a Health Care Innovation degree from Harvard Business School, and a minor in Cognitive Neuroscience from Copenhagen University.

dont miss

Improving Neurorehabilitation through Gaming and Digital Therapy

Combining the knowledge of neuroscience with gameplay, neurogaming is set to be a major disruptor in the future of healthcare. Incorporating sensory, cognitive, emotional and behavioral technologies, game creators are expected to be able to develop games that will improve both health and brainpower.

Games focused on attention, complex cognitive challenges and mindfulness are just the start as researchers look for solutions for patients suffering from cognitive impairments related to e.g. Traumatic Brain Injury, Stroke, Depression, Parkinson’s disease, Alzheimer’s disease.

Real computer games + validated neuroscience = Improved patient outcomes and quality of care

EVEN MORE SEMINARS

  • Matthew White MSc MCSP: Speaking at the European Neurological Convention

    Matthew White MSc MCSP
    Cyclone Technologies

    End Effector Gait Training – The G-Eo

  • Stephanie Huber: Speaking at the European Neurological Convention

    Stephanie Huber
    Restorative Therapies, on behalf of Cyclone Technologies

    Activity Based Restorative Therapy

  • Barry Richards: Speaking at the European Neurological Convention

    Barry Richards
    Ekso Bionics

    Ekso GT and Smart Assist – The new paradigm for neuro rehabilitation

  • Dr Jeremy Isaacs: Speaking at the European Neurological Convention

    Dr Jeremy Isaacs
    St George's University Hospitals NHS FT

    Diagnosis of young onset dementia

  • James S. Gyurke, Ph.D.: Speaking at the European Neurological Convention

    James S. Gyurke, Ph.D.
    ImPACT Applications, Inc.

    The importance of data based decision making in concussion management